$227.15
0.49% day before yesterday
NYSE, Nov 01, 09:00 pm CET
ISIN
US50540R4092
Symbol
LH

Laboratory Target price 2024 - Analyst rating & recommendation

Laboratory Classifications & Recommendation:

Buy
67%
Hold
33%

Laboratory Price Target

Target Price $263.69
Price $227.10
Potential
Number of Estimates 16
16 Analysts have issued a price target Laboratory 2025 . The average Laboratory target price is $263.69. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 21 analysts: 14 Analysts recommend Laboratory to buy, 7 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Laboratory stock has an average upside potential 2025 of . Most analysts recommend the Laboratory stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Billion $ 12.16 12.98
18.25% 6.77%
EBITDA Margin 14.02% 16.93%
29.50% 20.79%
Net Margin 3.28% 6.34%
58.20% 93.12%

16 Analysts have issued a sales forecast Laboratory 2024 . The average Laboratory sales estimate is

$13.0b
Unlock
. This is
2.14% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$13.0b 2.40%
Unlock
, the lowest is
$12.9b 1.75%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $12.2b 18.25%
2024
$13.0b 6.77%
Unlock
2025
$13.8b 6.29%
Unlock
2026
$14.5b 4.96%
Unlock
2027
$15.6b 7.53%
Unlock
2028
$16.5b 5.64%
Unlock

13 Analysts have issued an Laboratory EBITDA forecast 2024. The average Laboratory EBITDA estimate is

$2.2b
Unlock
. This is
24.92% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$2.3b 28.62%
Unlock
, the lowest is
$2.1b 22.08%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $1.7b 42.36%
2024
$2.2b 28.94%
Unlock
2025
$2.4b 8.50%
Unlock
2026
$2.5b 6.91%
Unlock
2027
$2.8b 9.47%
Unlock
2028
$3.0b 6.83%
Unlock

EBITDA Margin

2023 14.02% 29.50%
2024
16.93% 20.79%
Unlock
2025
17.28% 2.07%
Unlock
2026
17.60% 1.85%
Unlock
2027
17.92% 1.82%
Unlock
2028
18.12% 1.12%
Unlock

6 Laboratory Analysts have issued a net profit forecast 2024. The average Laboratory net profit estimate is

$823m
Unlock
. This is
90.62% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$1.0b 135.85%
Unlock
, the lowest is
$760m 75.97%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $399m 65.83%
2024
$823m 106.21%
Unlock
2025
$1.1b 29.77%
Unlock
2026
$1.2b 10.65%
Unlock
2027
$1.4b 20.15%
Unlock
2028
$1.6b 11.79%
Unlock

Net Margin

2023 3.28% 58.20%
2024
6.34% 93.12%
Unlock
2025
7.74% 22.08%
Unlock
2026
8.16% 5.43%
Unlock
2027
9.12% 11.76%
Unlock
2028
9.65% 5.81%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ 4.77 9.84
65.83% 106.29%
P/E 23.09
EV/Sales 1.94

6 Analysts have issued a Laboratory forecast for earnings per share. The average Laboratory <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$9.84
Unlock
. This is
90.70% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$12.17 135.85%
Unlock
, the lowest is
$9.08 75.97%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $4.77 65.83%
2024
$9.84 106.29%
Unlock
2025
$12.76 29.67%
Unlock
2026
$14.12 10.66%
Unlock
2027
$16.97 20.18%
Unlock
2028
$18.97 11.79%
Unlock

P/E ratio

Current 43.97 65.30%
2024
23.09 47.49%
Unlock
2025
17.79 22.95%
Unlock
2026
16.08 9.61%
Unlock
2027
13.38 16.79%
Unlock
2028
11.97 10.54%
Unlock

Based on analysts' sales estimates for 2024, the Laboratory stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.98 15.12%
2024
1.94 1.94%
Unlock
2025
1.83 5.92%
Unlock
2026
1.74 4.72%
Unlock
2027
1.62 7.01%
Unlock
2028
1.53 5.34%
Unlock

P/S ratio

Current 1.49 14.78%
2024
1.46 2.09%
Unlock
2025
1.38 5.91%
Unlock
2026
1.31 4.72%
Unlock
2027
1.22 7.01%
Unlock
2028
1.15 5.34%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today